进步软件公司
US ˙ NasdaqGS ˙ US7433121008

介绍

本页面提供了有关 Charles F Jr Wagner 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Charles F Jr Wagner已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:VRTX / Vertex Pharmaceuticals Incorporated EVP & Chief Financial Officer 51,671
US:BRKR / Bruker Corporation EVP & Chief Financial Officer 99,925
US:PRGS / Progress Software Corporation EVP Finance & Admin and CFO 50,000
如何解读这些图表

以下图表显示了在Charles F Jr Wagner进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

PRGS / Progress Software Corporation内部人士买入 - 短期收益分析

在这一部分,我们分析了在 PRGS / Progress Software Corporation 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

PRGS / Progress Software Corporation Insider Trades
PRGS / Progress Software Corporation内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 PRGS / Progress Software Corporation 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

PRGS / Progress Software Corporation Insider Trades
内幕交易历史

该表格显示了由 Charles F Jr Wagner 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2025-03-12 2025-03-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,298 51,671 -6.00 500.00 -1,649,000 25,835,500
2025-02-28 2025-02-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -4,962 54,969 -8.28 479.61 -2,379,825 26,363,682
2025-02-26 2025-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3,310 59,931 -5.23 483.28 -1,599,657 28,963,454
2025-02-19 2025-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2,293 63,241 -3.50 463.46 -1,062,714 29,309,674
2025-02-14 2025-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 6,655 65,534 11.30
2025-02-12 2025-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2,649 58,879 -4.31 467.98 -1,239,679 27,554,194
2025-02-06 2025-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 7,114 61,528 13.07
2025-02-06 2025-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 10,262 54,414 23.24
2024-11-13 2024-11-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,000 44,137 -6.36 518.27 -1,554,810 22,874,883
2024-06-05 2024-06-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,250 47,137 -6.45 460.00 -1,495,000 21,683,020
2024-05-30 2024-05-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,250 50,387 -6.06 454.79 -1,478,068 22,915,504
2024-02-27 2024-02-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3,309 53,583 -5.82 431.79 -1,428,793 23,136,604
2024-02-21 2024-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2,812 56,892 -4.71 420.58 -1,182,671 23,927,637
2024-02-21 2024-02-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3,750 59,704 -5.91 424.01 -1,590,038 25,315,093
2024-02-13 2024-02-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2,607 63,454 -3.95 422.74 -1,102,083 26,824,544
2024-02-08 2024-02-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 7,114 66,061 12.07
2024-02-08 2024-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9,440 58,947 19.07
2024-02-08 2024-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 5,814 49,507 13.31
2024-01-04 2024-01-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,000 43,693 -6.42 405.00 -1,215,000 17,695,665
2023-11-21 2023-11-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,000 46,693 -6.04 349.88 -1,049,640 16,336,947
2023-03-28 2023-03-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,768 49,611 -3.44 305.38 -539,912 15,150,207
2023-03-21 2023-03-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -16 51,379 -0.03 301.13 -4,818 15,471,758
2023-03-21 2023-03-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -240 51,395 -0.46 299.58 -71,899 15,396,914
2023-03-21 2023-03-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -360 51,635 -0.69 298.09 -107,312 15,391,877
2023-03-21 2023-03-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -240 51,995 -0.46 296.30 -71,112 15,406,118
2023-03-21 2023-03-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -784 52,235 -1.48 295.43 -231,617 15,431,786
2023-03-21 2023-03-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -360 53,019 -0.67 294.52 -106,027 15,615,156
2023-03-14 2023-03-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -62 53,379 -0.12 296.77 -18,400 15,841,286
2023-03-14 2023-03-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -292 53,441 -0.54 295.89 -86,400 15,812,657
2023-03-14 2023-03-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -715 53,733 -1.31 294.52 -210,582 15,825,443
2023-03-14 2023-03-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,153 54,448 -2.07 293.35 -338,233 15,972,321
2023-03-14 2023-03-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -420 55,061 -0.76 292.41 -122,812 16,100,387
2023-03-14 2023-03-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -24 56,021 -0.04 288.31 -6,919 16,151,415
2023-03-14 2023-03-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -102 56,045 -0.18 294.94 -30,084 16,529,912
2023-03-14 2023-03-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -27 56,147 -0.05 293.61 -7,927 16,485,321
2023-03-14 2023-03-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -185 56,174 -0.33 292.68 -54,146 16,441,006
2023-03-14 2023-03-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -541 56,359 -0.95 291.47 -157,685 16,426,958
2023-03-14 2023-03-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -30 56,900 -0.05 289.44 -8,683 16,469,136
2023-03-14 2023-03-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -327 56,930 -0.57 288.91 -94,474 16,447,646
2023-03-14 2023-03-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -515 57,257 -0.89 287.83 -148,232 16,480,282
2023-03-14 2023-03-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -361 57,772 -0.62 286.64 -103,477 16,559,766
2023-02-28 2023-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3,308 58,133 -5.38 289.12 -956,409 16,807,413
2023-02-22 2023-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3,750 61,441 -5.75 292.85 -1,098,188 17,992,997
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -4,992 65,191 -7.11 298.26 -1,488,914 19,443,868
2023-02-14 2023-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2,707 70,183 -3.71 294.33 -796,751 20,656,962
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9,440 72,890 14.88
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 10,262 63,450 19.29
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 10,324 53,188 24.09
2022-05-04 2022-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3 42,730 -0.01 264.37 -793 11,296,530
2022-05-04 2022-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -32 42,733 -0.07 262.06 -8,386 11,198,610
2022-05-04 2022-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -48 42,765 -0.11 261.15 -12,535 11,168,080
2022-05-04 2022-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -80 42,813 -0.19 259.45 -20,756 11,107,833
2022-05-04 2022-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -60 42,893 -0.14 258.21 -15,493 11,075,402
2022-05-04 2022-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 42,953 -0.23 257.18 -25,718 11,046,653
2022-05-04 2022-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -20 43,053 -0.05 254.87 -5,097 10,972,918
2022-05-03 2022-04-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -547 43,073 -1.25 276.17 -151,065 11,895,470
2022-04-05 2022-04-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -223 43,620 -0.51 266.68 -59,470 11,632,582
2022-04-05 2022-04-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -536 43,843 -1.21 265.95 -142,549 11,660,046
2022-04-05 2022-04-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,142 44,379 -2.51 265.06 -302,699 11,763,098
2022-04-05 2022-04-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -381 45,521 -0.83 263.67 -100,458 12,002,522
2022-04-05 2022-04-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -300 45,902 -0.65 261.42 -78,426 11,999,701
2022-03-21 2022-03-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -61 46,202 -0.13 251.05 -15,314 11,599,012
2022-03-21 2022-03-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,110 46,263 -6.30 250.13 -777,904 11,571,764
2022-02-28 2022-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2,189 49,373 -4.25 227.86 -498,786 11,250,132
2022-02-22 2022-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3,439 51,562 -6.25 232.51 -799,602 11,988,681
2022-02-14 2022-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2,434 55,001 -4.24 237.74 -578,659 13,075,938
2022-02-03 2022-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2,944 57,435 -4.88 250.07 -736,206 14,362,770
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 10,262 60,379 20.48
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 11,628 50,117 30.21
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 3,698 38,489 10.63
2021-05-05 2021-04-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -547 34,679 -1.55 217.21 -118,814 7,532,626
2021-02-26 2021-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -547 35,226 -1.53 217.57 -119,011 7,664,121
2021-02-12 2021-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2,365 35,773 -6.20 214.16 -506,488 7,661,146
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 11,627 38,138 43.86
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 10,324 26,511 63.78
2020-07-14 2020-07-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -260 16,126 -1.59 293.90 -76,414 4,739,431
2020-07-14 2020-07-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 16,386 -2.38 292.86 -117,144 4,798,804
2020-07-14 2020-07-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -40 16,786 -0.24 291.19 -11,648 4,887,915
2020-05-01 2020-04-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -547 16,727 -3.17 251.78 -137,724 4,211,524
2020-02-26 2020-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -542 17,274 -3.04 239.23 -129,663 4,132,459
2020-02-07 2020-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 10,323 17,816 137.77
2020-02-07 2020-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 3,698 7,493 97.44
2019-04-12 2019-04-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 9,532 9,532
2019-04-12 2019-04-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 3,697 3,697
2015-03-18 2015-03-17 4 BRKR BRUKER CORP
Common Stock
S - Sale -19,000 99,925 -15.98 18.97 -360,493 1,895,907
2014-09-04 2014-08-30 4 BRKR BRUKER CORP
Common stock
F - Taxes -3,062 118,925 -2.51 20.26 -62,036 2,409,420
2014-08-12 2014-08-08 4 BRKR BRUKER CORP
Stock Option (Right to Buy)
A - Award 49,400 49,400
2014-08-12 2014-08-08 4 BRKR BRUKER CORP
Common Stock
A - Award 25,895 121,987 26.95
2014-08-05 2014-08-02 4 BRKR BRUKER CORP
Common Stock
F - Taxes -10,476 96,092 -9.83 22.40 -234,662 2,152,461
2013-09-04 2013-08-30 4 BRKR BRUKER CORP
Stock Option (Right to Buy)
A - Award 46,698 46,698
2013-09-04 2013-08-30 4 BRKR BRUKER CORP
Common Stock
A - Award 25,726 106,568 31.82
2013-08-06 2013-08-02 4 BRKR BRUKER CORP
Common Stock
F - Taxes -7,186 80,842 -8.16 19.93 -143,217 1,611,181
2012-08-15 2012-08-13 4 BRKR BRUKER CORP
Stock Option (Right to Buy)
A - Award 5,000 5,000
2012-08-06 2012-08-02 4 BRKR BRUKER CORP
Common Stock
A - Award 88,028 88,028
2012-01-06 2012-01-05 4 BRKR BRUKER CORP
Stock Option (Right to Buy)
A - Award 6,000 6,000
2011-05-02 2011-04-28 4 PRGS PROGRESS SOFTWARE CORP /MA
Stock Option
A - Award 50,000 50,000
2011-05-02 2011-04-28 4 PRGS PROGRESS SOFTWARE CORP /MA
Stock Option
A - Award 14,000 59,456 30.80 29.64 414,960 1,762,276
2010-08-06 3 BRKR BRUKER CORP
No securities are beneficially owned
0
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)